APA
Gargano N., Madrid L., Valentini G., D'Alessandro U., Halidou T., Sirima S., Tshefu A., Mtoro A., Gesase S. & Bassat Q. (20190418). Efficacy and Tolerability Outcomes of a Phase II, Randomized, Open-Label, Multicenter Study of a New Water-Dispersible Pediatric Formulation of Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria in African Infants. : Antimicrobial agents and chemotherapy.
Chicago
Gargano Nicola, Madrid Lola, Valentini Giovanni, D'Alessandro Umberto, Halidou Tinto, Sirima Sodiomon, Tshefu Antoinette, Mtoro Ali, Gesase Samwel and Bassat Quique. 20190418. Efficacy and Tolerability Outcomes of a Phase II, Randomized, Open-Label, Multicenter Study of a New Water-Dispersible Pediatric Formulation of Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria in African Infants. : Antimicrobial agents and chemotherapy.
Harvard
Gargano N., Madrid L., Valentini G., D'Alessandro U., Halidou T., Sirima S., Tshefu A., Mtoro A., Gesase S. and Bassat Q. (20190418). Efficacy and Tolerability Outcomes of a Phase II, Randomized, Open-Label, Multicenter Study of a New Water-Dispersible Pediatric Formulation of Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria in African Infants. : Antimicrobial agents and chemotherapy.
MLA
Gargano Nicola, Madrid Lola, Valentini Giovanni, D'Alessandro Umberto, Halidou Tinto, Sirima Sodiomon, Tshefu Antoinette, Mtoro Ali, Gesase Samwel and Bassat Quique. Efficacy and Tolerability Outcomes of a Phase II, Randomized, Open-Label, Multicenter Study of a New Water-Dispersible Pediatric Formulation of Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria in African Infants. : Antimicrobial agents and chemotherapy. 20190418.